164 related articles for article (PubMed ID: 24068557)
1. Association of prediagnostic physical activity with survival following breast cancer diagnosis: influence of TP53 mutation status.
Tao MH; Hainaut P; Marian C; Nie J; Ambrosone C; Edge SB; Trevisan M; Dorn J; Shields PG; Freudenheim JL
Cancer Causes Control; 2013 Dec; 24(12):2177-86. PubMed ID: 24068557
[TBL] [Abstract][Full Text] [Related]
2. Influence of prediagnostic recreational physical activity on survival from breast cancer.
Cleveland RJ; Eng SM; Stevens J; Bradshaw PT; Teitelbaum SL; Neugut AI; Gammon MD
Eur J Cancer Prev; 2012 Jan; 21(1):46-54. PubMed ID: 21946863
[TBL] [Abstract][Full Text] [Related]
3. Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes.
McCullough LE; Chen J; Cho YH; Khankari NK; Bradshaw PT; White AJ; Teitelbaum SL; Terry MB; Neugut AI; Hibshoosh H; Santella RM; Gammon MD
Breast Cancer Res; 2017 Feb; 19(1):19. PubMed ID: 28222775
[TBL] [Abstract][Full Text] [Related]
4. TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance.
Silwal-Pandit L; Vollan HK; Chin SF; Rueda OM; McKinney S; Osako T; Quigley DA; Kristensen VN; Aparicio S; Børresen-Dale AL; Caldas C; Langerød A
Clin Cancer Res; 2014 Jul; 20(13):3569-80. PubMed ID: 24803582
[TBL] [Abstract][Full Text] [Related]
5. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
6. Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study.
Barron TI; Flahavan EM; Sharp L; Bennett K; Visvanathan K
Cancer Res; 2014 Aug; 74(15):4065-77. PubMed ID: 25085874
[TBL] [Abstract][Full Text] [Related]
7. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
[TBL] [Abstract][Full Text] [Related]
8. TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.
Lin CH; Chen IC; Huang CS; Hu FC; Kuo WH; Kuo KT; Wang CC; Wu PF; Chang DY; Wang MY; Chang CH; Chen WW; Lu YS; Cheng AL
Sci Rep; 2015 Dec; 5():17879. PubMed ID: 26671300
[TBL] [Abstract][Full Text] [Related]
9. Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer.
Chen X; Guo Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xu Y; Xie Y
J Cancer Res Clin Oncol; 2019 May; 145(5):1235-1242. PubMed ID: 30806788
[TBL] [Abstract][Full Text] [Related]
10. Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry.
Keegan TH; Milne RL; Andrulis IL; Chang ET; Sangaramoorthy M; Phillips KA; Giles GG; Goodwin PJ; Apicella C; Hopper JL; Whittemore AS; John EM
Breast Cancer Res Treat; 2010 Sep; 123(2):531-42. PubMed ID: 20140702
[TBL] [Abstract][Full Text] [Related]
11. Clinical spectrum and prognostic value of TP53 mutations in circulating tumor DNA from breast cancer patients in China.
Yi Z; Ma F; Rong G; Guan Y; Li C; Xu B
Cancer Commun (Lond); 2020 Jun; 40(6):260-269. PubMed ID: 32436611
[TBL] [Abstract][Full Text] [Related]
12. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.
Caan BJ; Kwan ML; Hartzell G; Castillo A; Slattery ML; Sternfeld B; Weltzien E
Cancer Causes Control; 2008 Dec; 19(10):1319-28. PubMed ID: 18752034
[TBL] [Abstract][Full Text] [Related]
13. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies.
Lahart IM; Metsios GS; Nevill AM; Carmichael AR
Acta Oncol; 2015 May; 54(5):635-54. PubMed ID: 25752971
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutations in breast cancer tumors of patients from Rio de Janeiro, Brazil: association with risk factors and tumor characteristics.
Simão TA; Ribeiro FS; Amorim LM; Albano RM; Andrada-Serpa MJ; Cardoso LE; Mendonça GA; de Moura-Gallo CV
Int J Cancer; 2002 Sep; 101(1):69-73. PubMed ID: 12209590
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
Schmidt MK; van den Broek AJ; Tollenaar RA; Smit VT; Westenend PJ; Brinkhuis M; Oosterhuis WJ; Wesseling J; Janssen-Heijnen ML; Jobsen JJ; Jager A; Voogd AC; van Leeuwen FE; van 't Veer LJ
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376189
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.
Schmidt MK; Tommiska J; Broeks A; van Leeuwen FE; Van't Veer LJ; Pharoah PD; Easton DF; Shah M; Humphreys M; Dörk T; Reincke SA; Fagerholm R; Blomqvist C; Nevanlinna H
Breast Cancer Res; 2009; 11(6):R89. PubMed ID: 20021639
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.
Johansson ALV; Trewin CB; Hjerkind KV; Ellingjord-Dale M; Johannesen TB; Ursin G
Int J Cancer; 2019 Mar; 144(6):1251-1261. PubMed ID: 30367449
[TBL] [Abstract][Full Text] [Related]
18. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer.
Overgaard J; Yilmaz M; Guldberg P; Hansen LL; Alsner J
Acta Oncol; 2000; 39(3):327-33. PubMed ID: 10987229
[TBL] [Abstract][Full Text] [Related]
19. Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer.
Ozcelik H; Pinnaduwage D; Bull SB; Andrulis IL
Breast Cancer Res Treat; 2007 Nov; 105(3):255-65. PubMed ID: 17221157
[TBL] [Abstract][Full Text] [Related]
20. Alcohol consumption and mortality after breast cancer diagnosis: The health and functioning in women study.
Din N; Allen IE; Satariano WA; Demb J; Braithwaite D
Breast Dis; 2016 Jul; 36(2-3):77-89. PubMed ID: 27662274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
